What's happened
A major review finds most IVF add-ons sold to patients show no robust evidence of benefit and may add financial and emotional strain, with only a few showing weak or marginal potential.
What's behind the headline?
Critical perspective
- The headline overstates the promise of add-ons; the data show most have no proven benefit.
- Behind the numbers, the influence of private clinics and marketing is clear, with cost and risk often underemphasized.
- The strongest signals point to rare, marginal benefits for EmbryoGlue and endometrial scratching, but these do not guarantee live birth improvements.
- Readers should seek independent, high-quality evidence and consult clinicians who disclose costs and uncertainties.
Forecast
- Expect ongoing scrutiny of IVF marketing and more publicly funded resources that present evidence-free claims as optional rather than essential.
- Patients will increasingly demand transparent trials and safer, cost-effective options.
How we got here
Researchers analyzed 85 high‑quality randomized trials among 157 eligible studies, concluding that many IVF add-ons do not improve outcomes and may mislead patients seeking hope. Clinics and social media are cited as major information sources driving demand.
Our analysis
Independent (Jane Kirby) — The Guardian (Andrew Gregory) — New York Times Business (Maggie Astor) The Independent reports a Lancet-studied review finding most add-ons lack robust evidence and warns against unnecessary costs. Andrew Gregory of The Guardian highlights the same, noting only a few add-ons show potential benefit. Maggie Astor in The New York Times underscores that few add-ons improve live birth rates, urging caution and cost consideration. All three emphasize misinformation and high commercial stakes in IVF markets.
Go deeper
- Should prospective IVF patients ask clinics to present trial data before any add-on is offered?
- What is the true cost of add-ons relative to potential benefits, and how should families plan for financial risk?
- Are independent online resources becoming more accessible for evidence-based guidance on IVF add-ons?
More on these topics
-
University of Melbourne - Public university in Melbourne, Australia
The University of Melbourne is a public research university located in Melbourne, Australia. Founded in 1853, it is Australia's second oldest university and the oldest in Victoria.
-
Intracytoplasmic Sperm Injection - In vitro fertilization procedure
Intracytoplasmic sperm injection is an in vitro fertilization procedure in which a single sperm cell is injected directly into the cytoplasm of an egg.
-
Australia - Country in Oceania
Australia, officially known as the Commonwealth of Australia, is a sovereign country comprising the mainland of the Australian continent, the island of Tasmania, and numerous smaller islands.